SF
Stephen F. Mahoney
DELAYED 1 MONTH
Director, President and CEO; President and CEO
Viridian Therapeutics, Inc.\DE
Filings
2
Companies
1
Latest
Mar 3, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
—
Viridian Therapeutics, Inc.\DE
Stephen F. Mahoney
President and CEO
Option Exercise
—
18,357 sh
Mar 4 11:56 PM
Mar 3, 2026